Artificial Intelligence (AI) in Healthcare Market Size, Industry Growth, CAGR, Segmentation & Future Opportunities 2025-2033

The global artificial intelligence in healthcare market was valued at USD 7.8 Billion in 2024 and is projected to reach USD 68.7 Billion by 2033. The market is expected to grow at a CAGR of 26.04% over the forecast period of 2025-2033. Major growth drivers include increasing demand for personalized medications, advancements in machine learning for medical image analysis, and the rising popularity of remote patient monitoring. Artificial Intelligence in Healthcare Market is transforming healthcare delivery and improving patient outcomes.

Study Assumption Years

Base Year: 2024
Historical Years: 2019-2024
Forecast Period: 2025-2033

Artificial Intelligence in Healthcare Market Key Takeaways

The global artificial intelligence in healthcare market size reached USD 7.8 Billion in 2024.
The market is expected to exhibit a CAGR of 26.04% during 2025-2033.
The forecast period for market growth is 2025-2033.
Software represents the largest offering segment, including EHR systems, imaging analysis, CDSS, and natural language processing tools.
Machine learning holds the largest share in the technology segment, powering diagnosis, prognosis, and image analysis.
Clinical trial participant identifier holds the biggest share among applications, ensuring data privacy and integrity.
Pharmaceutical and biotechnology companies are the dominant end-users, leveraging AI in drug discovery and precision medicine.
North America dominates the regional market due to its efficient medical infrastructure and high chronic disease prevalence.

Sample Request Link:
https://www.imarcgroup.com/artifical-intelligence-healthcare-market/requestsample

Market Growth Factors

The artificial intelligence in healthcare market is propelled by increasing demand for AI as it enhances medical research and accelerates drug development processes. The rising volumes of healthcare data, including digital electronic health records (EHR), medical images, and genomic information, fuel the adoption of AI-based solutions. These factors enhance the quality and speed of healthcare services, driving market growth.

Advancements in machine learning (ML) techniques offer improved analysis of medical images, anomaly detection, and accurate patient outcome predictions, supporting an optimistic market outlook. The growing demand for clinical decision support systems that provide evidence-based recommendations aids healthcare professionals in making informed decisions, facilitating better patient care and expanding AI usage.

The rising prevalence of chronic diseases due to inactive lifestyles (such as obesity, diabetes, and cardiovascular diseases) increases hospitalization rates and treatment demands. AI contributes by enhancing screening processes and detection capabilities for chronic illnesses. Furthermore, the popularity of remote patient monitoring devices, like smartwatches with emergency assistance and health tracking features, improves healthcare access and patient satisfaction, expanding the AI market.

Market Segmentation

Offering:

Hardware
Software
Services
Software dominates the market with solutions such as EHR systems, imaging analysis software, clinical decision support systems (CDSS), and natural language processing (NPL) tools. These software solutions digitally manage health records, analyze patient data, provide quantitative diagnostic measurements, and support real-time health monitoring.

Technology:

Machine Learning
Context Aware Computing
Natural Language Processing
Others
Machine learning holds the largest market share. ML algorithms analyze patient EHR, medical imaging, and genetic data to assist in diagnosis, prognosis, and treatment outcome predictions. ML enhances diagnostic accuracy, shortens interpretation time, and supports early disease detection.

Application:

Robot-Assisted Surgery
Virtual Nursing Assistant
Administrative Workflow Assistance
Fraud Detection
Dosage Error Reduction
Clinical Trial Participant Identifier
Preliminary Diagnosis
Others
Clinical trial participant identifier is the largest application segment. It assigns anonymous identifiers to trial participants, protecting privacy, ensuring data integrity, reducing errors, and preventing sensitive information misuse.

End-User:

Healthcare Providers
Pharmaceutical and Biotechnology Companies
Patients
Others
Pharmaceutical and biotechnology companies hold the largest market share. They leverage AI for drug discovery, development, and precision medicine by analyzing biological and chemical data, predicting drug activity, optimizing design, and identifying patient subgroups for targeted therapies.

Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

North America leads the global artificial intelligence in healthcare market with the largest market share, attributed to its advanced medical infrastructure and high prevalence of chronic diseases. Robust technology adoption including cloud computing and data storage in healthcare further drives market expansion.

Regional Insights

North America dominates the artificial intelligence in healthcare market due to its efficient medical infrastructure and rising chronic disease prevalence. For instance, in 2018, over 51.8% of adults in the U.S. had at least one diagnosed chronic condition, with 27.2% suffering from multiple conditions. The region's strong adoption of technology infrastructure solidifies its leading position.

Recent Developments & News

September 2024: Salesforce launched a new library of AI-enabled solutions targeting healthcare to automate clinical workflows and enhance patient care quality and efficiency.
September 2024: Tempus AI, Inc. introduced Olivia, an AI-powered personal health concierge platform for holistic health data management.
September 2024: Harrison.ai unveiled Harrison.rad.1, a vision-language AI model tailored for radiology, enabling image feature identification, report generation, and clinical reasoning.

Key Players

Amazon Web Services Inc.
Cloudmedx Inc.
DeepMind
Enlitic Inc.
General Vision Inc.
Google Inc.
International Business Machines
iCarbonX
Intel Corporation
Medtronic
Micron Technology Inc.
Microsoft Corporation
Next It Corporation
Nuance Communications Inc.
Nvidia Corporation
Siemens Healthcare
Welltok Inc.

Get Custom Market Research Report for Your Business:
https://www.imarcgroup.com/request?type=report&id=2079&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.